Strand Genomics changes corporate identity to Strand Life Sciences
Strand Genomics, announced that it has changed its corporate identity to Strand Life Sciences, effective immediately. It also announced the launch of its in silico predictive ADMET tool, admetis.
"The change in corporate identity reflects the expanding focus of the company. Our portfolio of products now extends beyond functional genomics into computational chemistry.," said Vijay Chandru, CEO and Chairman, Strand Life Sciences.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

The veins in your brain don't all act the same
S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors

Are bioplastics and plant-based materials safer than conventional plastics? - Biomaterials contain up to 20.000 chemicals
Rice physicists kill cancer with 'nanobubbles'
Thermo Fisher Scientific Announces Collaborative Partnership with Vascular Proteomics Group at King's College London

Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign’s Nanocyclix technology to Sanofi’s kinase targets
Researchers trace effects of genetic defect in myotonic muscular dystrophy
Analytica closes with outstanding results in all areas
